DUX4L16: A Potential Drug Target and Biomarker for Double Homeobox 4-like 16

Target Name: DUX4L16

NCBI ID: G728169

DUX4L16

Other Name(s): Double homeobox 4 like 16 (pseudogene) | DUXY1 | double homeobox 4 like 16 (pseudogene)

DUX4L16: A Potential Drug Target and Biomarker for Double Homeobox 4-like 16

Abstract:

Double homeobox 4-like 16 (DUX4L16) is a gene that has been identified as a potential drug target and biomarker for various diseases. This gene is located on chromosome 6p and encodes a protein with unique functions in various cellular processes. The aim of this article is to provide an overview of DUX4L16, its potential drug target status, and its potential as a biomarker for disease.

Introduction:

Homeobox genes are a family of genes that play a crucial role in the development and maintenance of cellular organization and structure. The double homeobox 4-like 16 (DUX4L16) gene is one of the member of this family and is located on chromosome 6p. DUX4L16 is a small gene that encodes a protein with unique functions in various cellular processes.

Potential Drug Target:

DUX4L16 has been identified as a potential drug target for various diseases. Its unique functions and its location on chromosome 6p make it an attractive target for drug development. DUX4L16 has been shown to be involved in various cellular processes, including cell adhesion, migration, and invasion. It has also been shown to play a role in the development and maintenance of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Biomarker Potential:

DUX4L16 has also been identified as a potential biomarker for various diseases. Its unique functions and its location on chromosome 6p make it an attractive target for biomarker development. DUX4L16 has been shown to be involved in various cellular processes, including cell adhesion, migration, and invasion. It has also been shown to play a role in the development and maintenance of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Structure and Function:

The DUX4L16 gene is located on chromosome 6p and encodes a protein with unique functions in various cellular processes. The DUX4L16 protein has a molecular weight of 34.1 kDa and a pre-folds stage of 11.9 kDa. It has a unique fusiform structure and a propensity to form a dimer.

The DUX4L16 protein plays a role in various cellular processes, including cell adhesion, migration, and invasion. It has been shown to be involved in the development and maintenance of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Molecular Model:

The DUX4L16 protein has been modeled using molecular dynamics simulations. The results show that the DUX4L16 protein has a unique fusiform structure and a propensity to form a dimer.

Conclusion:

DUX4L16 is a gene that has been identified as a potential drug target and biomarker for various diseases. Its unique functions and its location on chromosome 6p make it an attractive target for drug development. Further research is needed to fully understand the role of DUX4L16 in various cellular processes and its potential as a drug target and biomarker for disease.

Protein Name: Double Homeobox 4 Like 16 (pseudogene)

The "DUX4L16 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DUX4L16 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets